163 related articles for article (PubMed ID: 32999280)
1. Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf.
Xu Y; Sun T; Zeng K; Xu M; Chen J; Xu X; Zhang Z; Cao B; Tang X; Wu D; Kong Y; Zeng Y; Mao X
Cell Death Dis; 2020 Sep; 11(9):818. PubMed ID: 32999280
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis.
Sun T; Xu Y; Xu Z; Cao B; Zhang Z; Wang Q; Kong Y; Mao X
Cell Commun Signal; 2021 Feb; 19(1):24. PubMed ID: 33627137
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
Xu Y; Xu M; Tong J; Tang X; Chen J; Chen X; Zhang Z; Cao B; Stewart AK; Moran MF; Wu D; Mao X
Blood; 2021 Mar; 137(11):1478-1490. PubMed ID: 32842143
[TBL] [Abstract][Full Text] [Related]
4. Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.
Li H; Zhu X; Sun Z; Wang Q; Song S; Xu Y; He G; Mao X
ACS Pharmacol Transl Sci; 2024 Jan; 7(1):176-185. PubMed ID: 38230274
[TBL] [Abstract][Full Text] [Related]
5. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
Chen XH; Xu YJ; Wang XG; Lin P; Cao BY; Zeng YY; Wang Q; Zhang ZB; Mao XL; Zhang T
Acta Pharmacol Sin; 2019 Dec; 40(12):1568-1577. PubMed ID: 31197245
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
Wang S; Juan J; Zhang Z; Du Y; Xu Y; Tong J; Cao B; Moran MF; Zeng Y; Mao X
Cell Death Dis; 2017 Sep; 8(9):e3058. PubMed ID: 28933784
[TBL] [Abstract][Full Text] [Related]
8. Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity.
Asano K; Kikuchi K; Takehara M; Ogasawara M; Yoshioka Y; Ohnishi K; Iwata A; Shimizu S; Tanaka M
Biochem Biophys Res Commun; 2023 Dec; 684():149135. PubMed ID: 37879249
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
[TBL] [Abstract][Full Text] [Related]
10. Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma.
Jiang Q; Mao H; He G; Mao X
Cancer Lett; 2022 Sep; 543():215791. PubMed ID: 35700821
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
[TBL] [Abstract][Full Text] [Related]
12. The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.
Du Y; Liu Y; Xu Y; Juan J; Zhang Z; Xu Z; Cao B; Wang Q; Zeng Y; Mao X
J Biol Chem; 2018 Apr; 293(16):5847-5859. PubMed ID: 29467225
[TBL] [Abstract][Full Text] [Related]
13. Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria.
Chen Y; Wang YG; Li Y; Sun XX; Dai MS
Oncotarget; 2017 Feb; 8(7):11053-11062. PubMed ID: 28035068
[TBL] [Abstract][Full Text] [Related]
14. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.
Qiang YW; Ye S; Chen Y; Buros AF; Edmonson R; van Rhee F; Barlogie B; Epstein J; Morgan GJ; Davies FE
Blood; 2016 Dec; 128(25):2919-2930. PubMed ID: 27793878
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues.
Chen G; Xu X; Tong J; Han K; Zhang Z; Tang J; Li S; Yang C; Li J; Cao B; Zhou H; Wu D; Moran MF; Mao X
Int J Biochem Cell Biol; 2014 Dec; 57():157-66. PubMed ID: 25448412
[TBL] [Abstract][Full Text] [Related]
16. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.
Wang YQ; Zhang QY; Weng WW; Wu Y; Yang YS; Shen C; Chen XC; Wang L; Liu KJ; Xu MD; Sheng WQ
Int J Biol Sci; 2016; 12(5):545-57. PubMed ID: 27019636
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.
Hurt EM; Wiestner A; Rosenwald A; Shaffer AL; Campo E; Grogan T; Bergsagel PL; Kuehl WM; Staudt LM
Cancer Cell; 2004 Feb; 5(2):191-9. PubMed ID: 14998494
[TBL] [Abstract][Full Text] [Related]
19. A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23).
Morito N; Yoh K; Maeda A; Nakano T; Fujita A; Kusakabe M; Hamada M; Kudo T; Yamagata K; Takahashi S
Cancer Res; 2011 Jan; 71(2):339-48. PubMed ID: 21224354
[TBL] [Abstract][Full Text] [Related]
20. OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.
Iglesias-Gato D; Chuan YC; Jiang N; Svensson C; Bao J; Paul I; Egevad L; Kessler BM; Wikström P; Niu Y; Flores-Morales A
Mol Cancer; 2015 Jan; 14(1):8. PubMed ID: 25623341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
